The aim of this study was to compare the complication rates between transrectal ultrasound (TRUS) systematic prostate biopsy and multiparametric magnetic resonance imaging (MRI)-TRUS fusion prostate biopsy techniques.
This is a single-center retrospective study, institutional review board approved. Systematic TRUS and MRI-TRUS fusion prostate biopsy complication rates were compared in 967 men. A total of 319 patients were received systematic TRUS prostate biopsy and 648 patients underwent systematic TRUS + MRI-TRUS fusion prostate biopsy. Complications were divided into immediate (those that occurred during the hospital observation period) and late (those that occurred within 5 days after biopsy).
Seventeen complications were observed in patients who received either a systematic prostate biopsy or MRI-TRUS fusion prostate biopsy. Severe complications were not observed in both groups. Among patients who underwent systematic prostate biopsy, 6 (1.9%) cases of complications were observed and between those who received MRI-TRUS fusion prostate biopsy 11 (1.7%) cases of complications after the procedure (p = 0.873) were observed, with no statistical difference between groups. Also, no statistical differences between early and late complication groups (p > 0.999) were observed.
The complication rates were low in both groups, with no critical clinical outcomes and no significant difference of complication rates between systematic TRUS prostate biopsy and MRI-TRUS fusion prostate biopsy techniques.
Abdominal radiology (New York). 2018 Sep 25 [Epub ahead of print]
Marcos R G Queiroz, Priscila M Falsarella, Guilherme Cayres Mariotti, Gustavo C Lemos, Ronaldo H Baroni, Thais Caldara Mussi, Rodrigo G Garcia
Department of Interventional Radiology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Department of Interventional Radiology, Hospital Israelita Albert Einstein, São Paulo, Brazil. ., Department of Urology, Hospital Israelita Albert Einstein, São Paulo, São Paulo, 05652-000, Brazil., Department of Radiology, Hospital Israelita Albert Einstein, São Paulo, São Paulo, 05652-000, Brazil.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/30255444
Go Beyond the Abstract and Read a Commentary by the Author